Hudbay Minerals Inc. (HBM)vsSanofi ADR (SNY)
HBM
Hudbay Minerals Inc.
$25.02
+4.91%
BASIC MATERIALS · Cap: $9.47B
SNY
Sanofi ADR
$43.31
+0.30%
HEALTHCARE · Cap: $103.45B
Smart Verdict
WallStSmart Research — data-driven comparison
Sanofi ADR generates 1895% more annual revenue ($47.35B vs $2.37B). HBM leads profitability with a 27.8% profit margin vs 16.0%. HBM appears more attractively valued with a PEG of 2.09. HBM earns a higher WallStSmart Score of 77/100 (B+).
HBM
Strong Buy77
out of 100
Grade: B+
SNY
Buy51
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-71.4%
Fair Value
$15.42
Current Price
$25.02
$9.60 premium
Margin of Safety
+25.0%
Fair Value
$62.70
Current Price
$43.31
$19.39 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 40.0%
Earnings expanding 91.9% YoY
Keeps 28 of every $100 in revenue as profit
Attractively priced relative to earnings
Revenue surging 27.3% year-over-year
Reasonable price relative to book value
Large-cap with strong market position
Strong operational efficiency at 20.0%
Generating 1.7B in free cash flow
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Distress zone — elevated risk
ROE of 6.6% — below average capital efficiency
Expensive relative to growth rate
Earnings declined 11.7%
Comparative Analysis Report
WallStSmart ResearchBull Case : HBM
The strongest argument for HBM centers on Operating Margin, EPS Growth, Profit Margin. Profitability is solid with margins at 27.8% and operating margin at 40.0%. Revenue growth of 27.3% demonstrates continued momentum.
Bull Case : SNY
The strongest argument for SNY centers on Price/Book, Market Cap, Operating Margin. Profitability is solid with margins at 16.0% and operating margin at 20.0%.
Bear Case : HBM
The primary concerns for HBM are PEG Ratio, Piotroski F-Score, Altman Z-Score.
Bear Case : SNY
The primary concerns for SNY are Return on Equity, PEG Ratio, EPS Growth.
Key Dynamics to Monitor
HBM profiles as a growth stock while SNY is a mature play — different risk/reward profiles.
HBM carries more volatility with a beta of 2.15 — expect wider price swings.
HBM is growing revenue faster at 27.3% — sustainability is the question.
SNY generates stronger free cash flow (1.7B), providing more financial flexibility.
Bottom Line
HBM scores higher overall (77/100 vs 51/100), backed by strong 27.8% margins and 27.3% revenue growth. SNY offers better value entry with a 25.0% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Hudbay Minerals Inc.
BASIC MATERIALS · COPPER · USA
Hudbay Minerals Inc., a diversified mining company, focuses on the discovery, production and marketing of base and precious metals in North and South America. The company is headquartered in Toronto, Canada.
Visit Website →Sanofi ADR
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company is headquartered in Paris, France.
Compare with Other COPPER Stocks
Want to dig deeper into these stocks?